SHC reported $255 million in revenue in 2Q23, a decline of 4.3% but beat on EPS. I reiterate a hold rating due to ongoing weaknesses in Nelson Labs and prolonged inventory destocking issues. Margins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback